Helen of Troy (HELE) Q1 2027 earnings summary
Event summary combining transcript, slides, and related documents.
Q1 2027 earnings summary
9 Jul, 2026Executive summary
Q1 FY27 consolidated net sales grew 8.2% year-over-year to $402.1 million, with both Home & Outdoor and Beauty & Wellness segments contributing to growth and improved POS trends.
GAAP diluted EPS was $1.51, including a $1.74 after-tax gain from the sale of a distribution facility; adjusted diluted EPS was $0.17, down from $0.41 in Q1 FY26.
The company implemented a new GM-led operating model to drive agility, accountability, and international expansion, supporting innovation and commercial discipline.
FY27 marks the first phase of a multi-year plan focused on consumer-centric innovation, operational excellence, and talent investment.
Net income reached $35.8 million, reversing a net loss of $450.7 million in the prior year, driven by the absence of large asset impairment charges and the gain on the facility sale.
Financial highlights
Gross profit margin declined 110 basis points to 46.0% due to tariffs, inventory obsolescence, and less favorable mix.
Adjusted operating margin was 4.0% (down from 4.3% prior year); adjusted EBITDA margin was 6.3% (down from 6.9%).
Adjusted net income fell 58.3% to $4.0 million; adjusted diluted EPS dropped to $0.17 from $0.41.
Operating income was $60.3 million (15.0% margin), including a $54.9 million gain on the facility sale.
Net cash used by operating activities was $0.6 million, compared to $58.3 million provided last year.
Outlook and guidance
FY27 net sales guidance raised to $1.759–$1.831 billion; Home & Outdoor: $859–$884 million, Beauty & Wellness: $900–$947 million.
Adjusted EBITDA expected at $190–$197 million; adjusted EPS at $3.25–$3.75; free cash flow at $85–$100 million.
Outlook reflects Q1 overperformance, order pull-forward, and supply chain risks from Middle East conflict, with continued inflation and competitive pressures assumed.
Tariff refund benefit of $9.2 million included, but more than offset by cost inflation from commodities, currency, and freight; future tariff refunds not yet assumed.
Net leverage ratio targeted at 3.2x or lower by year-end.
Latest events from Helen of Troy
- Q2 sales and margins fell, but guidance, cash flow, and $500M buyback remain on track.HELE
Q2 20259 Jul 2026 - Net loss driven by asset impairments and lower sales, with guidance reflecting ongoing tariff headwinds.HELE
Q3 20268 Jul 2026 - Shareholders will vote on key governance, compensation, and equity plan changes amid ongoing transformation.HELE
Proxy filing24 Jun 2026 - Board recommends approval of all proposals, including director elections and compensation.HELE
Proxy filing24 Jun 2026 - Sales and margins fell on tariffs and impairments; FY27 targets recovery and debt reduction.HELE
Q4 202623 Apr 2026 - Prioritizing high-growth brands, revenue focus, and global expansion to drive long-term value.HELE
28th Annual ICR Conference 20263 Feb 2026 - Sales and earnings fell sharply, prompting lower guidance and continued restructuring.HELE
Q1 20253 Feb 2026 - All proposals passed as the company focuses on brand revitalization and operational transformation.HELE
AGM 202423 Jan 2026 - $240M acquisition of a high-growth nail brand, immediately accretive and diversifying the portfolio.HELE
M&A Announcement12 Jan 2026